May 17, 2013
Med BioGene Inc. Comments on Market Activity
April 18, 2013
Med BioGene Announces Adoption of Advance Notice Policy
April 15, 2013
Med BioGene Announces Date of Annual and Special Meeting
April 09, 2013
Med BioGene Reports Financial Results for 2012
March 27, 2013
Med BioGene Announces New Marketing Name for Lung Cancer Test
February 25, 2013
Med BioGene Provides Update on Litigation With Signal Genetics LLC and Respira Health LLC
January 23, 2013
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx™ Clinical Studies; Precision Therapeutics Prepares for Commercial Launch
Med BioGene Inc.
Phone: (800) 641-3593
To contact us by e-mail, please complete the form below with a description of your inquiry.
Beautiful Vancouver, British Columbia.
Subscribe to our e-mail news alerts
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer